Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Modern Chinese Medicine Group Co. Ltd. ( (HK:1643) ) has shared an announcement.
Modern Chinese Medicine Group Co., Ltd. has disclosed that the Securities and Futures Commission found a high concentration of its shares among 25 shareholders and related parties as of 30 March 2026, who collectively held 90.6% of the issued share capital. This leaves just 9.4% of shares in the hands of other investors, raising concerns about trading dynamics and market depth.
During the same period, the company’s share price surged sharply, rising 316% from HK$0.51 at the end of 2025 to HK$2.12 on 30 March 2026, and further to HK$2.94 by 13 April 2026, a 476% increase from year-end 2025. While the board confirms it continues to meet the Hong Kong public float requirement of at least 25%, it warns that the high shareholding concentration could lead to substantial price volatility on relatively small trading volumes and may limit the existence of a genuine market in the stock, urging investors to exercise extreme caution.
More about Modern Chinese Medicine Group Co. Ltd.
Modern Chinese Medicine Group Co., Ltd., incorporated in the Cayman Islands and listed in Hong Kong under stock code 1643, operates in the pharmaceutical and healthcare sector with a focus on modern Chinese medicine. The company serves investors in the Hong Kong equity market and is subject to the city’s securities and listing regulations.
Average Trading Volume: 3,081,203
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.17B
See more insights into 1643 stock on TipRanks’ Stock Analysis page.